slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
13,711-13,740 of 319,975
09
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Problem1 hit
10
McKinsey & Company branding present.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
11
The chart uses a combination of bar chart and trend line with growth rate annotations.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
12
The chart highlights a shift in the proportion of PII candidates between 2005 and 2015 using callout arrows.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
13
The table and charts show a clear trend of increasing blockbuster vaccine products despite a decrease in total launches.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
14
The chart uses a broken axis between 2015 and 2020.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
15
The chart uses a grouped bar chart format to compare two categories (Vx and Rx) over time. The source is Evaluate Pharma, February 2016.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
16
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
17
The chart highlights a -21% delta between the contribution of new launches in 2011 vs 2015.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
18
The slide highlights the shift in R&D activity towards smaller players and emerging markets.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
19
The slide uses a bar chart to compare attrition rates and a list of specific industry examples to illustrate the point.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
20
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Agitate1 hit
21
The slide uses three separate line charts to illustrate the divergence in profitability trends between vaccine divisions and other pharma/OTC divisions.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
22
The slide uses a bar chart to illustrate the convergence of success rates between vaccines and biologics, supporting the argument that vaccines are becoming less attractive for investment compared to biologics.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
23
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
24
The slide highlights a 27% increase in time to market between 2003-08 and 2009-14.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
25
The slide uses a list format to present case examples of operational risks.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
26
The slide uses a side-by-side comparison structure to define evaluation criteria for vaccine development.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
27
The slide uses a 2x2 matrix to illustrate the shift in innovation difficulty. The top-right quadrant is highlighted with a checkmark to represent past successes.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
28
The slide uses a numbered list format to define archetypes.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
29
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · Solution1 hit
30
The slide uses a numbered list format to align specific strategic interventions with market segments (High income/nosocomial, Incremental improvements, Emerging threats, Potential blockbusters, Low income).Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · SolutionLoop · Quick Win Big Bet1 hit
31
The slide uses a numbered list format to map specific strategic interventions to five distinct categories.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting Beat · SolutionLoop · Quick Win Big Bet1 hit
32
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
33
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
34
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
35
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
36
Refueling Innovation Engine VaccinesRefueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
37
The table contains a likely typo in the row labels (PII appears twice) and the notes below the table reference drops that do not align with the provided data values.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit
38
The table tracks sales figures and annual growth rates (p.a) across specific time intervals, with qualitative commentary on growth drivers.Refueling Innovation Engine Vaccines · McKinsey
Consulting deck Strategy consulting 1 hit